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Highlights 
 
The sarcopenia phenotype of mice lacking CuZnSOD in all tissues is not recapitulated in mice with a 
neuron specific deletion of CuZnSOD (nSod1KO mice) 
 
Neuronal loss of CuZnSOD reduces force generation to a small extent, but mass is not reduced in the 
gastrocnemius muscle in 20 month old mice, a muscle that is highly sensitive to age related loss of 
muscle mass and strength 
 
Loss of CuZnSOD in neuronal tissue alters NMJ morphology and induces moderately markers of muscle 
denervation; however, it does not initiate neuromuscular junction degeneration, loss of innervation or 
increases in oxidative stress or mitochondrial generation of ROS.  
 
Our data support the concept that deficits in either the motor neuron or muscle alone are not sufficient 
to initiate a full sarcopenic phenotype. 
  
Abstract.   
Our previous studies showed that adult (8 month) mice lacking CuZn-superoxide dismutase (CuZnSOD, 
Sod1KO mice) have neuromuscular changes resulting in dramatic accelerated muscle atrophy and 
weakness that mimics age-related sarcopenia.  We have further shown that loss of CuZnSOD targeted to 
skeletal muscle alone results in only mild weakness and no muscle atrophy. In this study we targeted 
deletion of CuZnSOD specifically to neurons (nSod1KO mice) and determined the effect on muscle mass 
and weakness.  The nSod1KO mice show a significant loss of CuZnSOD activity and protein level in brain 
and spinal cord but not in muscle tissue. The masses of the gastrocnemius, tibialis anterior and extensor 
digitorum longus (EDL) muscles were not reduced in nSod1KO compared to wild type mice, even at 20 
months of age, although the quadriceps and soleus muscles showed small but significant reductions in 
mass in the nSod1KO mice. Maximum isometric specific force was reduced 8% to 10% in the 
gastrocnemius and EDL muscle of nSod1KO mice, while soleus was not affected. Muscle mitochondrial 
ROS generation and oxidative stress measured by levels of reactive oxygen/nitrogen species (RONS) 
regulatory enzymes, protein nitration and F2-isoprostane levels were not increased in muscle from the 
nSod1KO mice. Although we did not find evidence of denervation in the nSOD1KO mice, neuromuscular 
junction morphology was altered and the expression of genes associated with denervation (acetylcholine 
receptor subunit alpha (AChRα)  and the transcription factors Runx1 and GADD45α) was increased, 
 supporting a role for neuronal loss of CuZnSOD initiating alterations at the neuromuscular junction.  These 
results and our previous studies support the concept that deficits in either the motor neuron or muscle 
alone are not sufficient to initiate a full sarcopenic phenotype and that deficits in both tissues are required 
to recapitulate the loss of muscle observed in Sod1KO mice.  
 
 
  
Introduction 
Our previous studies have provided significant insight into potential mechanisms of sarcopenia using 
mice that lack CuZn-superoxide dismutase (CuZnSOD), i.e., Sod1KO mice, as a model of age-related muscle 
atrophy.  Although indistinguishable from wild type mice at birth, by 5-8 months of age, gastrocnemius 
muscles of Sod1KO mice display significant reductions in mass and function that progress through 
adulthood, such that by 20 months of age Sod1KO mice resemble 30-month-old wild type mice (Muller et 
al., 2006, Jang et al., 2010, Larkin et al., 2011). In addition, both Sod1KO mice and old wild type mice 
exhibit profound alterations in neuromuscular innervation in conjunction with the initiation of skeletal 
muscle atrophy (Jang et al., 2010). Post-synaptic endplates are severely disrupted, the number of 
acetylcholine receptors (AChRs) is reduced and the receptors are significantly fragmented. Finally, 
mitochondrial function is reduced and mitochondrial ROS generation is elevated in both adult Sod1KO 
mice and old wild type mice.  Overall, our findings in the Sod1KO mice point to the significance of 
neuromuscular interaction in maintenance of mitochondrial function and muscle mass and suggest that 
disruption of the neuromuscular junction (NMJ) might be a trigger for declines in muscle mass and 
function during aging.  
Because muscle and motor neurons are integrally related by structure and function, the question has 
always arisen as to the relative roles of these two tissues in the mechanism responsible for muscle 
atrophy. Similar questions have been raised in the field of ALS and other neuromuscular diseases in which 
muscle atrophy and weakness are a predominant phenotype. The observation that Sod1KO mice replicate 
the sarcopenia phenotype observed in old wild type mice provides us with the ability to use genetic 
approaches to dissect out the role of the motor neuron and muscle in sarcopenia and to begin identifying 
key pathways in these tissues that are critical in the loss in muscle mass and function. Our first study 
showed that replacing CuZnSOD specifically in the motor neurons in Sod1KO mice (nSOD1-Tg/Sod1KO 
mice) prevented muscle atrophy and weakness, as well as the NMJ degeneration associated with loss of 
mass and function. These data suggested that motor neuron deficits resulting from oxidized redox status 
are a key initiating event in sarcopenia in the Sod1KO mice (Sakellariou et al., 2014). In contrast, deleting 
Sod1 specifically in skeletal muscle (mSod1KO mice) had no effect on either muscle atrophy or NMJ 
degeneration (Zhang et al., 2013a), demonstrating that loss of Sod1 in muscle alone is not sufficient to 
generate atrophy. Based on our experiments with the nSOD1-Tg/Sod1KO and mSod1KO mice, we 
speculated that the loss of Sod1 in the motor neuron was the critical feature contributing to the 
sarcopenia observed in the whole body Sod1 mice. Thus, we hypothesized that neuronal specific Sod1KO 
(nSod1KO) mice would recapitulate the phenotype of the Sod1KO mice.  To test this hypothesis, we 
generated a neuronal specific knockout mouse using our Sod1-floxed mouse crossed to transgenic mice 
expressing Cre recombinase driven by the nestin promoter (nestin-Cre transgenic mice) and compared 
nSod1KO and wild type mice for muscle atrophy and weakness, as well as a number of parameters that 
we had previously measured in the Sod1KO mice, including muscle properties such as fiber diameter and 
myonuclear domain, oxidative stress and markers of altered redox, changes in acetyl choline receptor 
morphology and markers of denervation. Contrary to our hypothesis, our results show that loss of 
neuronal CuZnSOD was not sufficient to induce muscle atrophy and weakness that is observed in the 
Sod1KO mice.  
  
Materials and Methods 
Generation of neuron-specific Sod1-knockout (nSod1KO) mice.  Details of the generation of the 
Sod1flox/flox mice was reported in our earlier publication (Zhang et al., 2013).  To generate nSod1KO mice, 
Sod1flox/flox mice were bred with a mouse strain that expresses Cre recombinase under the control of the 
nestin promotor [(B6.Cg(SJL)-Tg(Nes-cre)1Kln/J)] that we obtained from Jackson laboratory (Bar Harbor, 
ME,USA). Mice were maintained on a 12-hr dark/light cycle and provided with food and water ad libitum. 
At sacrifice, mice were euthanized by CO2 inhalation and tissues were immediately excised and weighed. 
All the tissues, except those used for immunostaining, were snap frozen and stored at −80°C.  All animal 
protocols were consistent with The Guide for the Care and Use of Laboratory Animals and approved by 
the Institutional Animal Care and Use Committee at Oklahoma Medical Research Foundation (OKC, OK, 
USA). 
Measurement of CuZnSOD and MnSOD activity.  CuZnSOD and MnSOD activity in brain, spinal cord and 
muscle were determined using native gels as described (Van Remmen et al., 1999). 
CuZnSOD immunoblot analysis.  Equal amounts of protein from brain, spinal cord, gastrocnemius and 
quadriceps muscle were resolved by SDS-PAGE and transferred to PVDF membrane. The membranes were 
blocked and probed with CuZnSOD (Enzo Life Sciences, Inc. Farmingdale, NY, USA) and GAPDH (Sigma, St. 
Louis, MO, USA) antibodies overnight at 4 C. Membranes were washed extensively and incubated with 
secondary antibodies linked to horseradish peroxidase (Santa Cruz Biotechnology, Dallas, TX, USA). 
Proteins were visualized using enhanced chemiluminescence reagent and signal intensities were 
quantified using Image J 1.45b software (developed by Wayne Rasband, National Institute of Health, 
Bethesda, MD) 
Western blotting of RONS proteins in skeletal muscle.  Muscles were ground in a motor and pestle under 
liquid nitrogen and frozen muscle powder was placed into RIPA buffer containing 50 mM Tris (pH 7.4), 
150 mM NaCl, and protease inhibitors. Samples were homogenized on ice and centrifuged at 10.000g for 
10min at 4oC. Protein content of samples was determined using the bicinchoninic acid method (Sigma-
Aldrich, Poole, UK). For assessment of specific proteins in muscle, 20μg of total protein was applied to a 
4-20% mini-PROTEAN TGX precast gel with a 4% stacking gel (Biorad Laboratories Ltd, Hemel Hempstead, 
UK). The separated proteins were transferred onto nitrocellulose membranes by western blotting. 
Membranes were probed using antibodies against MnSOD (SOD2), (Stressgen Inc., UK), eNOS, iNOS, PRXV, 
and GAPDH (Abcam, Cambridge, UK). Horseradish peroxidase conjugated anti-rabbit IgG or anti-mouse 
IgG, (Cell Signalling, Hitchin, UK) was used as secondary antibody. Peroxidase activity was detected using 
an ECL Plus substrate (Amersham International Cardiff, UK), and band intensities were analysed using 
Quantity One Software (Biorad Laboratories Ltd). The specificity of the bands was identified in comparison 
with a sample that had not been exposed to the primary antibody and the molecular weight was 
determined by using molecular weight markers. All protein contents were normalized to the GAPDH 
content of the same sample.  
Analyses of the 3-nitrotyrosine (3-NT) content of muscle proteins. Total cellular protein was isolated and 
20µg was separated by SDS-PAGE followed by western blotting as describe above. The separated proteins 
were transferred onto polyvinylidene difluoride (PVDF) membranes. The content of 3-NT was analysed by 
using a rabbit monoclonal antibody (Cell Biolabs, San Diego, USA), as per the manufacturer’s instructions. 
Bands were visualized and densitometric quantiﬁcation was undertaken using Quantity One Software 
(Biorad Laboratories Ltd).  
Analysis of F2-isoprostanes.  Levels of F2-isoprostanes in quadriceps muscle was measured as decribed 
(Ward et al, 2005, Zhang et al., 2013). Briefly, 200mg of tissue was homogenized in 10 ml of ice-cold Folch 
solution (CHCl3: MeOH, 2:1) containing butylated hydroxytoluene (BHT). The mixture was incubated at 
room temperature for 30min. 2 ml of 0.9% NaCl was added and mixed well. The homogenate was 
centrifuged at 3000 × g for 5 minutes at 4°C. The aqueous layer was discarded while the organic layer was 
secured and evaporated to dryness under N2 at 37°C. Esterified F2-isoprostanes were measured using gas 
chromatography-mass spectrometry.  The level of F2-isoprostanes in muscle tissues was expressed as 
nanograms of 8-Iso-PGF2α, per gram of muscle tissue.   
Real-time PCR.  Total RNA was extracted from the gastrocnemius and quadriceps of the wild type and 
nSod1KO mice using TRIzol reagent (Life Technologies, Grand Island, NY, USA). RNA purity and yield were 
determined by measuring the absorbance at 260 and 280nm. cDNA were prepared from 1ug of the total 
RNA using iScriptTM cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA). 2.5ng of cDNA samples were 
amplified using fast SYBR green master mix and primers for AChRα, Musk, Rapsyn, Runx1, GADD45a and 
18S (Applied Biosystems, Grand Island, NY, USA). The data were analyzed using the ΔΔCt method. 
Contractile Force. Mice were anesthetized by intraperitoneal injection of Avertin (tribromoethanol, 250 
mg/kg) supplemented to maintain an adequate level of anesthesia during all procedures. Gastrocnemius 
muscle contractile properties were measured in situ, as described by Larkin et al. (2011). Anesthetized 
mice were placed on a platform warmed to maintain body temperature at 37°C. The gastrocnemius 
muscle was isolated from surrounding tissues and the distal tendon was securely tied to the lever arm of 
a servomotor (model 6650LR, Cambridge Technology). The knee and foot were clamped to the platform.  
A continual drip of saline warmed to 37°C was applied to the gastrocnemius muscle to maintain its 
temperature.  The muscle was activated by stimulation of the tibial nerve.  With the muscle held at optimal 
length (Lo), 300-ms trains of stimulus pulses were applied at increasing stimulation frequencies until the 
maximum isometric tetanic force (Po) was achieved. Contractile properties were measured for extensor 
digitorum longus and soleus muscles in vitro as described by Brooks and Faulkner (1988). Muscles were 
placed in a horizontal bath containing buffered mammalian Ringer solution maintained at 25°C and tied 
to a force transducer (model BG-50, Kulite Semiconductor Products, Leonia, NJ) and a servomotor (model 
305B, Aurora Scientific, Aurora, ON).  Muscles were stimulated by platinum plate electrodes connected 
to a high-power biphasic current stimulator (model 701B, Aurora Scientific). Muscles were held at Lo and 
subjected to trains of pulses of 300 ms duration for EDL muscles and 900 ms for soleus muscles. Stimulus 
frequency was increased until the Po was achieved.   
After muscles were removed, deeply anesthetized mice were euthanized by pneumothorax and 
removal of a vital organ. Muscles were trimmed of their tendons, blotted and weighed. Fiber lengths (Lf) 
were estimated by multiplying Lo by previously determined Lf-to-Lo ratios (Larkin et al., 2011, Brooks and 
Faulkner, 1988), and physiological cross-sectional areas (CSA) of the muscles were determined by dividing 
the mass of the muscle by the product of Lf and 1.06 g/cm3, the density of mammalian skeletal muscle. 
The specific Po was determined by dividing Po by the physiological CSA.  
Neuromuscular Junction (NMJ) imaging. For imaging acetylcholine receptors (AchRs), longitudinal muscle 
sections were permeabilized with 1% triton X-100 for 1 hour at room temperature and then incubated 
with Alexa Fluor 647-conjugated bungarotoxin (Molecular Probes, Eugene, OR, USA) diluted in PBS and 
1% triton X-100 for one hour at room temperature. Sections were washed with PBS and mounted in 
Vectashield (Vector Laboratories, Peterborough, UK). Immune fluorescence imaging was obtained with a 
Nikon TE2000U microscope.  
Analysis of fiber diameter, nuclei number and myonuclear domain.  Gastrocnemius and quadriceps 
muscles were dissected, weighed and immediately placed in relaxing solution at 4oC {0.1 M KCl, 0.01 M 
imidazole (pH 7.0), 1mM MgCl2, 2 mM EGTA and 4.5 mM ATP}. The bundles of ≈ 50-100 fibers were 
dissected in the chilled relaxing solution and chemically skinned in relaxing solution containing 50% (v/v) 
glycerol for 24 h at 4oC and stored at -20oC for up to 4 weeks before use. On the day of the experiment, 
single fiber segments were gently dissected free from the bundle and carefully placed on the glass slide. 
After a brief permeabilization with 0.1% Triton X-100, fibers were stained with rhodamine-phalloidin 
(1:200, Molecular Probe Inc., Eugene, OR, USA) for 45 minutes and DAPI (Invitrogen, Molecular Probes, 
OR, USA) for 5 minutes followed by final washes. Linear fiber segments of ≈350-450µm were chosen for 
imaging. All images were captured with a Nikon TE2000U inverted fluorescence microscope equipped 
with a 20 x phase-contrast objective (NA 0.45) and imported into Image J software (developed by Wayne 
Rasband, National Institute of Health, Bethesda, MD) for analysis. 
MyHC isoforms composition by gel electrophoresis. In short, the myosin heavy chain (MyHC) isoform 
composition of the muscle was determined by SDS-PAGE as previously described (Larsson et al., 1993). 
The total acrylamide and bis concentration were 4% (w/v) in the stacking gel and 8% in the running gel, 
and the gel matrix included 30% glycerol. Sample loads were kept small to improve the resolution of the 
MyHC bands, and the electrophoresis was performed at 120 V for 24 h with a Tris-glycine electrode buffer 
(pH = 8.3) at 4°C. 
Mitochondrial H2O2 generation.  Intact isolated mitochondria from the gastrocnemius muscles were used 
to measure reactive oxygen species (ROS) generation indirectly as H2O2 release using the fluorescent 
probe Amplex Red (Molecular Probes, Eugene, OR, USA) as described previously (Muller et al., 2007, 
Zhang et al., 2013). The assay was performed in 100ul of reaction buffer that contained 125 mM KCl, 10 
mM HEPES, 5 mM MgCl2, and 2 mM K2HPO4 (pH 7.44) along 20-50 μg of mitochondrial protein with and 
without respiratory substrates GM (2.5 mM glutamate and 2.5 mM malate) at 37°C. Amplex Red oxidation 
by H2O2 every 2 s for ∼10 min at an excitation of 545 nm and an emission of 590 nm was measured using 
a Fluoroskan-FL Ascent Type 374 multiwell plate reader (Labsystems, Helsinki, Finland). 
Statistical analysis.  Data are presented as mean ± SEM or SD for each experiment as detailed in the figure 
legends. Comparisons among the three groups were performed by analysis of variance (ANOVA) while 
Student’s t-test was performed to compare 2 groups. Data were analyzed using SPSS 22 or Prism 6 and p 
values of less than 0.05 were considered statistically significant.   
  
Results. 
Generation and characterization of a conditional mouse model with reduced CuZnSOD targeted to 
neuronal tissue. NesCre x Sod1flox/flox mice (nSod1KO mice) are expected to show a reduction in CuZnSOD 
expression in neuronal tissue with no change in CuZnSOD expression in other tissues (i.e., in muscle). As 
shown in Figure 1, nSod1KO mice show a dramatic reduction in the activity (Figure 1A) and protein levels 
(Figure 1B) of CuZnSOD in brain and spinal cord.  In contrast, CuZnSOD activity and level in gastrocnemius 
and quadriceps muscle from nSod1KO mice are equivalent to the values measured in wild type mice.  Thus, 
the nSod1KO mice we have generated shows a neuron specific loss of CuZnSOD and normal levels of 
muscle CuZnSOD, giving us a model to test directly the role that reduced CuZnSOD in neurons plays in the 
loss of muscle mass and and NMJ disaggregation that is observed in Sod1KO mice.   
Effect of neuronal depletion of CuZnSOD on muscle mass and strength. Our previous studies showed 
that Sod1KO mice have significant muscle atrophy in a number of muscles.  For example, the mass of lower 
hind limb muscles, in particular the gastrocnemius muscle, a muscle that undergoes a significant loss of 
mass during aging (Muller et al., 2006, Larkin et al., 2011), is reduced by 30-45% by 20 months of age 
(Muller et al., 2006, Larkin et al., 2011, Jang et al., 2012). We have also reported that muscle strength, as 
measured by specific force, is reduced in Sod1KO mice approximately 50% at 8 month of age (Larkin et al., 
2011).  We measured muscle mass in a number of individual hind limb muscles in 17- to 20-month-old 
wild type and nSod1KO mice.  As shown in Figure 2A, mass was not altered in the gastrocnemius, tibialis 
anterior or extensor digitorum longus muscles, while quadriceps (~14%) and soleus muscles (less than 
10%) showed small but significant reduction in mass.  Muscle-specific effects were also evident in 
measures of contractile force (Figure 2B). Despite no change in mass, both the extensor digitorum longus 
and gastrocnemius showed small but significant reductions (~10%) in specific force. In contrast, the soleus 
muscle, which showed a reduction in mass, showed no loss of force generation.  
Changes in muscle properties in gastrocnemius and quadriceps muscle from wild type and nSod1KO 
mice. Because the gastrocnemius and quadriceps muscle showed differential changes in mass in response 
to the neuronal depletion of CuZnSOD, we measured a number of additional properties of these two 
muscles.  We previously reported a significant reduction in fiber diameter in gastrocnemius muscle of 20-
month-old Sod1KO mice compared to wild type mice as well as a reduction in the number of nuclei present 
per mm of muscle fiber (Jang et al., 2010) .The myonuclear domain (MND), which is a measure of the 
cytoplasmic domain per myonucleus, was not different in wild type and Sod1KO mice. We measured the 
fiber diameter in a total of 361 muscle fibers from gastrocnemius and quadriceps muscles of wild type 
(N=5, n=225) and nSod1KO (N=3, n=136) mice. In contrast to muscles of Sod1KO mice, the data in Figure 
3A show there was no significant difference in fiber diameter between the two experimental groups in 
either muscle. We also measured the number of nuclei per mm of fiber length and calculated the size of 
the MNDs along the length of single muscle fiber linear segments. We found no difference in the number 
of nuclei per unit length between the wild type and nSod1KO mice in either muscle (Figure 3B).  The MND 
was not altered in the gastrocnemius muscle, but was slightly reduced in fibers from the quadriceps 
muscle from nSod1KO mice, reflecting a trend for a reduction in fiber size but unchanged nuclei count 
when compared to wild type muscle (Figure 3B).  Both gastrocnemius and quadriceps muscle from 
nSod1KO mice showed increased numbers of fibers with central nuclei (Figure 3C).  This is in agreement 
with our previous finding of an increased numbers of central nuclei in gastrocnemius muscle from Sod1KO 
mice (Jang et al., 2012). The increase in central nuclei may suggest an increase in degeneration and 
regeneration of quadriceps muscle fibers in the nSod1KO mice compared to wild type mice.  Single muscle 
fiber size, force generation and the nuclei count vary between glycolytic and oxidative fibers and the 
changes described above can be influenced by the change in muscle fiber type composition. However, as 
shown in Figure 3D, we do not report a fiber type transition between gastrocnemius and quadriceps 
muscles from wild type and nSod1KO mice. 
Changes in NMJ morphology and markers of denervation. One of the most robust changes we have 
reported in the Sod1KO mice are changes NMJ structure and function and a loss of innervation and (Jang 
et al., 2010, Sakellariou et al., 2014, Shi et al., 2014). These same changes occur with age in wild type mice 
(Jang et al., 2012). To determine whether a selective loss of neuronal CuZnSOD can lead to alterations in 
NMJs and loss of innervation, we examined AChR morphology using immunostaining and quantified the 
changes in receptor endplate area. During aging, muscle atrophy is associated with fragmentation of 
AChRs, changes in shape and a reduction in receptor endplate area and we also observed these changes 
in muscle from the Sod1KO mice (Jang et al., 2012). As shown in Figure 4A, we found a significant reduction 
in endplate area in both gastrocnemius and quadriceps muscle from nSod1KO mice compared to age 
matched wild type mice but no evidence of fragmentation.  To determine if the nSod1KO mice showed 
changes in innervation, we measured the induction of expression of acetylcholine receptor alpha (AChRα) 
and two other markers known to increase transiently in skeletal muscle following denervation, the 
transcription factors Runx1 and GADD45α (Figure 4B). The transcripts for these three genes were 
increased significantly in the gastrocnemius muscle from both Sod1KO and nSod1KO mice compared to 
wild type mice.  We found similar increases in these genes in quadriceps muscle from the nSod1K mice 
(right panel in Figure 4B). However, the expression of two additional genes associated with the NMJ (MuSK 
and rapsyn) whose expression is increased with denervation, was not increased.  These data suggest a 
morphological change in the AChR consistent with changes seen in the initiation of denervation; however, 
the NMJ fragmentation and denervation that occurs in muscle from the Sod1KO mice is not seen in the 
nSod1KO mice. 
Changes in mitochondrial function and oxidative damage. One of the most robust alterations we have 
measured in response to denervation is mitochondrial dysfunction, especially an increase in generation 
of H2O2 by isolated muscle mitochondria and increased oxidative damage. For example, we have reported 
dramatic increases in H2O2 in isolated muscle mitochondria from muscle after sciatic nerve transection 
and nerve crush (Muller et al., 2007, Walsh et al., 2015).  Using the fluorescent probe Amplex Red, we 
measured H2O2 generation in mitochondria isolated from gastrocnemius of wild type and 17-22 month 
old nSod1KO mice (Figure 5A).  H2O2 generation was not significantly increased during State 1 respiration 
(no exogenous substrate provided) or in response to glutamate and malate as substrates in the 
gastrocnemius muscle of the nSod1KO mice.   
We have shown that the increased generation of ROS by mitochondria in the Sod1KO mice and other 
mouse models of denervation results in increased oxidative stress as measured by oxidative damage ( 
Jang et al., 2010, Muller et al., 2007). To determine whether oxidative damage is elevated in muscle from 
nSod1KO mice as we have previously reported in muscle from Sod1KO mice (Zhang et al., 2013b), we 
measured F2-isoprostane levels, a marker of lipid peroxidation, in quadriceps muscle from wild type 
Sod1KO and nSod1KO mice (Figure 5B).  F2-isoprostanes were elevated more than 30% in quadriceps 
muscle from Sod1KO mice compared to muscle from wild type mice, but were not elevated in muscle from 
the nSod1KO mice.  Our previous studies show that loss of skeletal muscle mass in the Sod1KO mice is 
associated with increased oxidative damage and compensatory up-regulation of RONS regulatory 
enzymes ( Sakellariou et al., 2011, Sakellariou et al., 2014). To determine whether protein nitration is 
increased in muscle from the nSod1KO mice, we measured the levels of protein nitration (Figure 6A) and 
the protein content of PRXV (Figure 6B), a peroxynitrite reductase. No significant differences were 
observed in gastrocnemius muscle between wild type and nSod1KO mice. To further assess muscle redox 
changes, we measured the expression of RONS regulatory enzymes including MnSOD, eNOS and iNOS 
(Figure 7).  Similar to our results on protein nitration in the gastrocnemius, no significant difference in 
expression of RONS regulatory enzymes was detected in muscle tissue from nSod1KO mice compared with 
wild type mice, indicating no change in the overall redox status in muscle of nSod1KO mice.  
  
Discussion. 
Aging is accompanied by a 30% to 40% reduction in skeletal muscle mass and function that is the 
main cause of frailty and loss of independence in the elderly (Roubenoff and Hughes, 2000). This 
phenomenon, called sarcopenia, is universal to all mammalian species, and is observed even in the 
absence of disease. The loss of muscle mass involves both loss of muscle fibers and, to a lesser extent, 
atrophy of the remaining muscle fibers. Aging in skeletal muscle is associated with an increased number 
of fibers per motor unit and fiber type grouping consistent with a cycle of continual denervation and 
reinnervation (Essen-Gustavsson and Borges, 1986, Larsson and Edstrom, 1986). In addition to the 
changes that occur in muscle tissue, parallel changes have also been reported in motor neurons during 
aging that have been proposed to play an important role muscle atrophy, including loss of motor neurons 
and alterations in axonal sprouting (Fagg et al., 1981). While the etiology of sarcopenia is poorly 
understood, several potential contributing factors have been identified, including loss of innervation, 
muscle mitochondrial dysfunction, and oxidative stress (Fulle et al., 2004, Kadhiresan et al., 1996). 
Sod1KO mice, lacking CuZnSOD in all tissues, have elevated levels of oxidative damage and a 
significantly shortened lifespan (30% reduction) compared to wild type mice (Zhang et al., 2013, Elchuri 
et al., 2005).  The lifespan of the Sod1KO mice can be restored to that of wild type mice by dietary 
restriction ( Zhang et al., 2013b).  In addition, many aging phenotypes are accelerated in the Sod1KO mice, 
e.g., loss of hearing and hair, thinning of skin, cataracts, and early onset of muscle atrophy (Muller et al., 
2006, Elchuri et al., 2005, McFadden et al., 1999).  The accelerated loss of muscle in the Sod1KO mice is 
similar in essentially every respect to the sarcopenia observed with aging in wild type mice (Jang et al., 
2011). These similarities include an age-dependent decrease in muscle mass (both absolute and relative 
to body mass) with the greatest decrease occurring in the gastrocnemius, with the greatest decrease 
occurring in the gastrocnemius, a muscle profoundly affected by aging in wild type mice; a higher 
percentage of smaller muscle fibers, evident even in adult (8 month old) Sod1KO mice; and a failed 
adaptive response (Visilaki et al., 2010). The reduction in muscle mass is 30% to 45% in hind limb muscle 
mass in Sod1KO mice by 20 months of age whereas wild type mice show little change in hind limb muscle 
mass until after 26 months of age ( Muller et al., 2006). The accelerated loss of muscle mass is associated 
with neuronal changes, again, similar to those described in old wild type mice.  These include the loss of 
functional innervation ( Larkin et al., 2011)) with gross alterations in NMJ morphology, including reduced 
occupancy of the motor endplates by axons, terminal sprouting, axon thinning, and irregular swelling with 
reduced motor neuron myelin thickness and fiber/axon diameter ( Muller et al., 2006, Shi et al., 2014, 
Hamilton et al., 2013).  The decrease in muscle mass and function and changes in neuronal structure and 
function are prevented in both adult Sod1KO and old wild type mice subjected to dietary restriction ( Jang 
et al., 2012, Zhang et al.,2013b).   
Using transgenic and knockout mouse models that conditionally express CuZnSOD, we have begun 
to define the role muscle and motor neurons play in the accelerated loss of muscle observed in the 
Sod1KO mice.  Our previous studies showed that (1) Sod1KO mice expressing CuZnSOD specifically in 
neuronal tissue (nSOD1-Tg/Sod1KO mice) were protected from the muscle atrophy and weakness as well 
as from the NMJ degeneration (Sakellariou et al., 2014) and (2) mSod1KO mice, in which Sod1 is deleted 
specifically in skeletal muscle, showed no muscle atrophy or NMJ degeneration (Zhang et al., 2013a).  
Based on the observation that the loss of CuZnSOD in muscle appeared to have very little effect on 
muscle atrophy, we proposed that the accelerated sarcopenia phenotype we observed in the Sod1KO 
mice occurred as a result of increased oxidative stress in the motor neurons, which led to NMJ 
dysfunction/disaggregation and the eventual loss of muscle mass and function, Thus, we predicted that 
deletion of CuZnSOD in neuronal tissue (in the nSod1KO mice) would recapitulate the sarcopenia 
phenotype observed in the Sod1KO mice. However, our data show that the mass of the gastrocnemius, 
which is the muscle showing the greatest atrophy in Sod1KO and old wild type mice, was not reduced in 
nSod1KO compared to wild type mice, even at 20 months of age.  In addition, no reduction in mass of 
the tibialis anterior and extensor digitorum longus muscles was observed in the nSod1KO mice.  At 20-
25 months of age, the Sod1KO mice show over a 50% decrease in the muscle mass of the gastrocnemius 
and a 19% to 25% decrease in the mass of the tibialis anterior and extensor digitorum longus muscles.  
We did observe a slight but significant decrease in the mass of the quadriceps and soleus muscles in the 
nSod1KO mice, which was similar to the decrease observed in Sod1KO mice.  Interestingly, the data from 
the mSod1KO and nSod1KO mice show that changes in muscle force generation and muscle mass appear 
to occur through separate mechanisms because muscle atrophy (quantity) and muscle weakness 
(quality) did not always parallel each other.  For example, gastrocnemius muscles of mSod1KO mice were 
weaker than those of wild type, as indicated by lower values for specific force (normalized for muscle 
cross-sectional area) even though the mass of the gastrocnemius muscles of the mSod1KO mice was 
slightly larger (nearly a 15-20% increase in mass relative to body weight in mSod1KO versus wild type 
mice).  I n the present study, we observed that the gastrocnemius and the extensor digitorum longus 
muscles from the nSod1KO mice were also significantly weaker than those of WT mice even though the 
masses of the muscles were not different between the nSod1KO and WT mice.  On the other hand, the 
soleus showed a decrease in muscle mass in the nSod1KO mice and a concomitant decrease in absolute 
force, but specific force was not different between nSod1KO and WT mice, indicating no qualitative 
change in the force generating capacity of the tissue. 
In contrast to the mSod1KO mice, we found that the nSod1KO mice at 17-22 months of age showed 
changes in NMJ morphology (reduced endplate area) and increased expression of AChRa, Runx1 and 
gadd45a, genes associated with denervation (Jang et al., 2010, Wang et al., 2005, Bongers et al., 2013).  
However, we did not observe any evidence of NMJ fragmentation in the nSod1KO mice.  In contrast, 
Sod1KO mice show evidence of NMJ fragmentation as early as 5 months of age (Jang et al., 2012).  These 
results suggest that deleting Sod1 in neuronal tissue has an effect on NMJ structure/function; however, 
this effect is much less severe than that which occurs in the Sod1KO mouse.  We have found the induction 
of production of reactive oxygen species by isolated muscle mitochondrial (mtROS, as measured by H2O2 
generation) and increased oxidative damage and stress in muscle to be consistently associated with NMJ 
fragmentation and denervation.  For example, mtROS is induced over 30-fold following sciatic nerve 
transection (Muller et al, 2007).  In addition, the level of mtROS production by muscle is correlated with 
the severity of muscle atrophy [e.g, mtROS increased approximately 30% in 30-month-old wild type mice, 
more than 50% in 20-month-old Sod1KO mice, and approximately 75% in muscle from symptomatic 
amyotrophic lateral sclerosis (ALS) mice (Muller et al, 2007) and dietary restriction dramatically reduces 
muscle atrophy and mtROS generation in muscle of the Sod1KO mice (Jang et al., 2012).  We did not 
observe any significant change in either mtROS generation, oxidative damage (measured by F2-
isoprostane or protein nitration levels), or oxidative stress (measured by RONS regulatory enzymes) in 
the muscle of the nSod1KO mice.  Thus, the changes we observed in the NMJs of the nSod1KO mice do 
not lead to changes in the muscle that we observe in the Sod1KO mice.  
Based on our data with the conditional knockout and transgenic mice, we propose that muscle 
atrophy in Sod1KO mice occurs through a “two-hit” mechanism involving changes in motor neurons and 
changes in muscle.  We propose that the “first hit” occurs when redox homeostasis is compromised in 
motor neurons resulting in alteration in NMJ morphology and function. The “second hit” occurs when 
the muscle mitochondria are altered (e.g., increased ROS production) in response to NMJ dysfunction 
and the alteration in muscle mitochondria triggers a retrograde response leading to increased NMJ 
damage, which in turn leads to further dysfunction in NMJs and motor neurons.  The increased NMJ 
dysfunction leads to a further increase in muscle mitochondrial dysfunction, resulting in a vicious cycle 
that ultimately results in NMJ fragmentation, denervation, loss of muscle fibers, and sarcopenia. 
Preventing the initial motor neuron defect, as in the nSOD1-Tg/Sod1KO mouse, prevents the 
mitochondria dysfunction and increased oxidative damage/stress in muscle as well as the cascade of 
events leading to sarcopenia even though the antioxidant defense system in the muscle is compromised.  
The mSod1KO mice, which show no NMJ fragmentation, mitochondria dysfunction, or oxidative 
damage/stress support the “two-hit” mechanism by showing that without the initial motor neuron 
dysfunction there is no trigger to induce mitochondria dysfunction in muscle mitochondria and 
therefore, no NMJ fragmentation, again indicating that the dysfunction in motor neurons/NMJ is 
necessary to initiate the mitochondria dysfunction in the muscle.  Finally, nSod1KO mice do not show 
muscle atrophy in most muscles because the initial motor neuron dysfunction does not trigger sufficient 
mitochondrial dysfunction and oxidative damage/stress in the muscle of the nSod1KO mice, which have 
an intact antioxidant defense system. Therefore, the nSod1KO mice lack the “second hit,” which would 
lead to the vicious cycle and increased NMJ dysfunction and fragmentation. 
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Figure legends 
Figure 1: Generation of neuron-specific Sod1-knockout (nSod1KO) mice. A) Native gels stained for 
CuZnSOD and MnSOD enzyme activities in gastrocnemius, quadriceps, brain and spinal cord of wild type 
and nSod1KO mice. B) Western blot analysis of CuZnSOD expression in gastrocnemius, quadriceps, brain 
and spinal cord of wild type and nSod1KO. (n=3-6 mice in each group between 7 and 18 months of age).  
Both males and females were used to generate these data. 
Figure 2: Muscle mass and function of the nSOD1KO mice. A) Muscle mass expressed as percentage of 
body mass. B) Maximum isometric specific force (N/cm2) of gastrocnemius, extensor digitorum longus and 
soleus muscle. (*p<0.05 vs wild type by Students t-test, n=8-10 mice per group, 20 month old mice, wild 
type -black bars, nSod1KO- white bars) 
Figure 3: Fiber diameter, type, myonuclear domain (MND) and number of nuclei in gastrocnemius and 
quadriceps muscle of the nSOD1KO mice. A) Percentage distribution of fiber diameter of gastrocnemius 
and quadriceps muscle. B) MND size from single muscle fiber segments of gastrocnemius and quadriceps. 
Rhodamine-phalloidin labeled actin is shown in red and nuclei visualized by DAPI in blue. Scale bar denotes 
50µm. C) Fibers with central nuclei in the gastrocnemius and quadriceps. D) Percentage of fiber type 
distribution in the gastrocnemius and quadriceps (*p=0.05 vs wild type by t-test, n= 3-7 mice in each 
group). 5 months and 20 months old mice were used. 
Figure 4: Acetylcholine receptor morphology and denervation associated markers in nSod1KO mice A). 
Acetylcholine receptors from gastrocnemius (GTN) (A, B, C, D) and quadriceps (Quad) muscles (E, F, G, H). 
(scale bar = 10mm for receptors and 40mm for clusters). B). mRNA levels of the denervation markers. In 
gastrocnemius,*p<0.001 nSod1KO vs wild type, *p<0.01 Sod1KO vs wild type for AChRα mRNA; *p<0.01 
nSod1KO vs wild type, *p<0.0001 Sod1KO vs wild type for Runx1 mRNA;*p<0.05 nSod1KO vs wild type, 
*p<0.001 Sod1KO vs wild type for GADD45α mRNA by analysis of variance (ANOVA) with comparisons 
between groups performed using Newman-Keuls post –hoc test using Prism6 software. In 
quadriceps,*p<0.01 nSod1KO vs WT for AChRα mRNA; *p<0.0001 nSod1KO vs WT for Runx1 
mRNA,*p<0.05 nSod1KO vs wild type for GADD45a mRNA by t-test. Mice were 16-18months of age and 
n= 4-13 mice per group. (WT -black bars, nSod1KO- white bars, Sod1KO- grey bars).  
Figure 5: Mitochondrial ROS measurement and F2-isoprostane levels in nSod1KO mice A) Hydrogen 
peroxide generation in mitochondria isolated from gastrocnemius muscle (n= 6-11 mice per group). B) F2-
isoprostane levels in quadriceps muscle (*p< 0.05 in wild type vs Sod1KO by Students t test; n= 3-5 mice 
per group) (wild type -black bars, Sod1KO – grey bars, nSod1KO- white bars).  
Figure 6: Markers of oxidative damage to proteins in nSOD1KO mice. A) Protein nitration in 
gastrocnemius and quadriceps. B) Expression of peroxynitrite reductase, PRXV in the gastrocnemius and 
quadriceps. (n=4 mice per group, 17-22 month old mice with quantification on the right) (wild type- black 
bars, nSOD1KO- white bars).  
Figure 7: RONS regulatory protein contents in nSOD1KO mice.  Expression of MnSOD, endothelial nitric 
oxide synthase (eNOS) and inducible NOS (iNOS) proteins of gastrocnemius and quadriceps by western 
blot with quantification on the right. (n=4mice per group, 17-22 month old mice) (wild type -black bars, 
nSOD1KO- white bars). 
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